(Q54368670)
Statements
Idarubicin combined with intermediate-dose cytosine arabinoside in the treatment of refractory acute leukemia. (English)
Leone G
Pagano L
Marra R
Di Pietro N
Storti S
Sica S
D'Onofrio G
Ganzina F
1 January 1989
74
1
57-61